Our mesenchymal stem cells (MSCs) are manufactured to the highest European cGMP standards, delivering unmatched purity, viability, and regenerative potential. Derived exclusively from fresh, non-frozen Wharton's Jelly, our MSCs are collected from screened, healthy donors and processed immediately to preserve cellular youthfulness and biological potency.
Every batch follows strict SOPs approved by the National Transplant Bureau and undergoes extensive quality, identity, and safety testing before release. The result is a clinical-grade MSC product with consistent performance, superior viability, and exceptional surface-marker purity.
Manufacturing Excellence
Fresh Processing
Direct processing at donation time preserves younger, more active MSC populations with higher colony-forming efficiency
cGMP Compliance
Pharmaceutical-level standards with validated cleanrooms and continuous environmental monitoring
Quality Assured
Every batch is sterile, endotoxin-tested, identity-verified, and contamination-free
Fresh Wharton's Jelly Processing
We process umbilical cord tissue directly at the time of donation, while most suppliers rely on frozen or cryo-stored material. This critical difference preserves the biological power and regenerative potential of our MSCs.
Younger Cell Populations
More active MSC populations with enhanced biological activity
Higher Colony-Forming Efficiency
Superior ability to proliferate and form new cell colonies
Improved Differentiation Capacity
Enhanced ability to transform into specialized cell types
Stronger Immunomodulatory Signaling
More powerful anti-inflammatory and immune-regulating properties
Rigorous Donor Screening
All donating mothers undergo comprehensive serological and PCR screening to ensure the highest safety standards. We specifically select donors with no COVID-19 vaccination, an important differentiation point for immune-purity–conscious clinics.
Complete Screening Panel
HIV-1 / HIV-2
Hepatitis B & C
CMV, EBV
Lyme (Borrelia)
Additional risk-factor exclusion
Donors are healthy individuals aged 18–44, ensuring optimal tissue quality and cellular vitality.
Superior Viability & Purity
88.6%
Post-Thaw Viability
Well above global thresholds for clinical applications
0.2
IU Endotoxin Level
Extremely low, passing European Pharmacopoeia standards
100M
MSCs Per Vial
High cell count for maximum therapeutic potential
Each vial contains up to 100 million MSCs, frozen in 80% cord blood plasma and 20% DMSO/DEX. These exceptional metrics confirm both safety and performance for clinical and ex vivo applications, ensuring consistent results across all therapeutic protocols.
Industry-Leading Marker Expression
The latest batch Certificate of Analysis demonstrates extraordinary purity of true MSC identity markers. This level of marker expression is rare—even among top global suppliers—and directly correlates with regenerative potency, anti-inflammatory behavior, and immune-modulating performance.
100%
CD73+
Perfect expression
99.6%
CD90+
Near-perfect purity
99.3%
CD105+
Exceptional quality
92.2%
SSEA3+
Outstanding marker
Each marker far exceeds minimum EU standards, confirming the exceptional quality and regenerative potential of our MSC products.
Comprehensive Safety Testing
Every lot undergoes rigorous testing using European Pharmacopoeia-approved methodologies to guarantee non-contaminated, safe, highly viable MSC product with flawless traceability.
01
Sterility Testing
Inoculation method ensures complete absence of contamination
02
Endotoxin Analysis
LAL method confirms ultra-low endotoxin levels
03
Viability Assays
Trypan blue or flow cytometric exclusion validates cell health
04
Identity Verification
Confirms authentic MSC characteristics and marker expression
Clinical & Ex Vivo Applications
Each vial is specifically manufactured for clinical and laboratory regenerative procedures. Our MSCs are designed to integrate seamlessly into advanced therapeutic protocols, providing clinicians and researchers with a reliable, high-performance cellular tool.
Therapeutic Applications
Tissue engineering
Ex vivo cell expansion
Combination protocols with exosomes
Orthobiologic interventions
Longevity-focused treatments
Handling instructions ensure that rapid thawing (less than 1 minute) maintains peak viability and biological activity.
Long-Term Cryostability
1
Liquid Nitrogen Storage
Stored in vapor phase for up to 3 years, maintaining full potency and viability
2
Short-Term Option
−80°C storage allowed for less than 1 month when needed
3
Operational Flexibility
Provides clinics and research centers with convenient storage options
Our advanced cryopreservation protocols ensure that MSCs retain their regenerative properties throughout the storage period, giving practitioners confidence in consistent therapeutic outcomes.
The MSCExos Advantage
Fresh Processing
Never frozen before manufacturing
cGMP Standards
Pharmaceutical-grade quality control
Rigorous Testing
Comprehensive safety verification
Superior Purity
Industry-leading marker expression
Unlocking Regenerative Potential: The Muse Cell Advantage
Muse cells (Multi-lineage Undifferentiated Stem Cells) are a rare, naturally occurring subpopulation within MSCs, offering significant advantages in regenerative medicine. With superior potency, pluripotency, and long-term engraftment, Muse cells represent a new frontier in cellular therapy.
Exceptional Potency
Up to 10x more potent than standard MSCs in various regenerative applications.
True Pluripotency
Capable of differentiating into virtually any cell type, from liver to neuronal to skin cells.
Long-Term Engraftment
Persist and integrate effectively within the body for extended therapeutic benefits.
Elevate Your Practice
Join MSCExos on your journey towards optimal health and longevity. Experience the transformative power of our innovative stem cell products and bring cutting-edge regenerative medicine to your patients.
Our clinical-grade MSCs represent the pinnacle of cellular therapy, combining fresh processing, pharmaceutical-level manufacturing, and exceptional purity. Partner with us to deliver superior therapeutic outcomes and advance the field of regenerative medicine.